Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis [0.03%]
利妥昔单抗低剂量治疗原发性膜性肾病的系统评价和 meta 分析
Gerry George Mathew,Shanmugam Sundaramurthy,Prakash Muthuperumal et al.
Gerry George Mathew et al.
Introduction. Rituximab (RTX) holds promise as a treatment for idiopathic membranous nephropathy (IMN). While effective in standard regimens, the application of RTX is hampered by cost burdens and severe side effects. To address these issue...
A Growing Public Health Problem in Europe with Potential Severe Renal Involvement [0.03%]
在欧洲日益严重的公共卫生问题，可能引发肾脏严重病变
Enrica Falbo,Tabassum Elahi,Imane Guermah
Enrica Falbo
Dengue is an arboviral infection transmitted by the mosquito of the Aedes genus, widespread especially in tropical and subtropical regions but now with worldwide involvement. Cases of contagion are also progressively increasing in Europe, a...
[Governo clinico in nefrologia: organizzazione e sviluppo della dialisi peritoneale] [0.03%]
[肾脏病的临床管理：腹膜透析的组织与开发]
Giovanni Cancarini,Stefano Santarelli,Valerio Vizzardi et al.
Giovanni Cancarini et al.
Gaetano La Manna
Gaetano La Manna
Gianfranca Cabiddu,Antonello Pani,Nicola Lepori
Gianfranca Cabiddu
Among the recent advancements in Peritoneal Dialysis, the guidelines on the prevention and treatment of peritonitis, published in March 2022 by the International Society for Peritoneal Dialysis (ISPD), are of particular importance. The ISPD...
Antonio Santoro,Annalisa Zucchelli
Antonio Santoro
The technique of dialysis has seen enormous advancements over the past fifty years, evolving from an initial phase, primarily based on diffusion through a semipermeable membrane to the current preference for high-efficiency convection, invo...
[The Treatment of Acute Antibody-Mediated Rejection: Current State and Future Perspectives] [0.03%]
急性抗体介导的排斥反应治疗现状与未来展望
Alessandra Palmisano,Ilaria Gandolfini,Micaela Gentile et al.
Alessandra Palmisano et al.
Despite the advances in the immunosuppressive therapies and improvements in short term allograft survival, Antibody-mediated rejection (AMR) still represents the leading cause of late allograft failure in kidney transplant recipients. We pr...
Luigi Biancone,Silvia Mingozzi,Rita Terragoni
Luigi Biancone
The renal transplant scenario has changed profoundly in the last two decades in both the typology of donors and recipients. This phenomenon has not been accompanied by a significant renewal of the therapeutic arsenal in maintenance therapy,...
Piergiorgio Messa,Shanmugam Sabarinath,Carlo Maria Alfieri et al.
Piergiorgio Messa et al.
The important advances in scientific knowledge have led to a notable enrichment of therapeutic offers in the field of CKD-MBD, which have allowed better control of the related biochemical parameters compared to the past. However, this has n...
[Biomarkers and Bone Turnover Markers in Chronic Kidney Disease - Mineral and Bone Disorders (CKD-MBD): Recent Advances] [0.03%]
慢性肾脏病-矿物质和骨代谢异常生物标志物及骨转换标志物的新进展
Althea Cossettini,Giulia Vanessa Re Sartò,Andrea Aghi et al.
Althea Cossettini et al.
Chronic Kidney Disease (CKD) provokes biochemical and systemic alterations, causing bone fragility with an increase in bone fracture risk, extraskeletal calcifications, increased morbidity, and cardiovascular mortality. The complex pathophy...